Aldeyra Therap

ALDX

0.95864.66% ( +0.0427 )

Closed: Oct 7, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -2.51, above the reasonable range, cheaper than 6.26% of the time in the past 3 years, and the industry ranks 303/602, the industry Median -2.07.

-2.51xP/E

Stock price$0.96Earnings per share$-0.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GILDUSGilead Sciences	-56.20x	148.77%	$182.09B
MRNAUSModerna	-24.89x	15.53%	$78.44B
CSLLYUSCSL Limited	-23.41x	--	$60.36B
NTRAUSNatera	-296.43x	6.99%	$57.02B
RVMDUSRevolution Medicines	-24.35x	62.27%	$43.05B
ROIVUSRoivant Sciences	-94.27x	146.49%	$25.10B
BNTXUSBioNTech SE	-12.22x	15.84%	$23.93B
INSMUSInsmed	-25.38x	74.34%	$22.22B
SMMTUSSummit Therapeutics	-16.73x	19.55%	$14.32B
BBIOUSBridgebio Pharma	-18.79x	28.48%	$13.00B
MDGLUSMadrigal Pharma	-34.66x	51.06%	$11.27B
IBRXUSImmunityBio	-10.41x	151.32%	$10.33B
TWSTUSTwist Bioscience	-74.95x	25.09%	$10.25B
PCVXUSVaxcyte	-9.36x	48.80%	$9.96B
KYMRUSKymera Therapeutics	-30.07x	4.94%	$9.01B
ARWRUSArrowHead Pharma	-27.14x	36,308.30%	$8.68B
CYTKUSCytokinetics	-9.50x	6.37%	$8.50B
PRAXUSPraxis Precision Medicines	-22.89x	3.05%	$7.76B
ABVXUSAbivax SA	-16.29x	22.49%	$7.59B
IONSUSIonis Pharma	-12.98x	50.60%	$7.34B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.